Open access · CC-BY
via OpenAlex
Mild phenotype in Molybdenum cofactor deficiency: A new patient and review of the literature
Barbara Scelsa, Serena Gasperini, Andrea Righini, Maria Iascone, Valeria G. Brazzoduro, Pierangelo Veggiotti
Molecular Genetics & Genomic Medicine · 2019 · ▲ 32 citations
Abstract
BACKGROUND: Molybdenum cofactor deficiency (MoCD) is a rare autosomal-recessive disorder that results in the combined deficiency of molybdenum-dependent enzymes. Four different genes are involved in Molybdenum cofactor biosynthesis: MOCS1, MOCS2, MOCS3, and GEPH. The classical form manifests in the neonatal period with severe encephalopathy, including intractable seizures, MRI changes that resemble hypoxic-ischemic injury, microcephaly, and early death. To date, an atypical phenotype with late-onset has been reported in the literature in 13 patients. METHODS: We describe a late-onset and a relatively mild phenotype in a patient with MOCS2 homozygous mutation. RESULTS: Pyramidal and extrapyramidal signs are recognized in those patients, often exacerbated by intercurrent illness. Expressive language is usually compromised. Neurological deterioration is possible even in adulthood, probably due to accumulation of sulfite with time. CONCLUSION: Sulfite inhibition of mitochondrial metabolism could be responsible for the ischemic lesions described in patients with MoCD or alternatively could predispose the brain to suffer an ischemic damage through the action of other insults, for instance intercurrent illness. It is possible that sulfite accumulation together with other external triggers, can lead to neurological deterioration even in adulthood. The role of other factors involved in clinical expression should be investigated to establish the reason for phenotypic variability in patients with the same mutation.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1002/mgg3.657
- Canonical
- link ↗
- Fetched
- 2026-06-24 MST
Cite this
APA
Scelsa, B., Gasperini, S., Righini, A., Iascone, M., Brazzoduro, V.G., & Veggiotti, P. (2019). Mild phenotype in Molybdenum cofactor deficiency: A new patient and review of the literature. <em>Molecular Genetics & Genomic Medicine</em>. https://doi.org/10.1002/mgg3.657
Vancouver
Scelsa B, Gasperini S, Righini A, Iascone M, Brazzoduro VG, Veggiotti P. Mild phenotype in Molybdenum cofactor deficiency: A new patient and review of the literature. Molecular Genetics & Genomic Medicine. 2019. doi:10.1002/mgg3.657.
BibTeX
@article{barbara2019Mildph,
title = {Mild phenotype in Molybdenum cofactor deficiency: A new patient and review of the literature},
author = {Barbara Scelsa and Serena Gasperini and Andrea Righini and Maria Iascone and Valeria G. Brazzoduro and Pierangelo Veggiotti},
journal = {Molecular Genetics & Genomic Medicine},
year = {2019},
doi = {10.1002/mgg3.657},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
BMC Geriatrics 2021
Open access · CC-BY
Reproducibility and responsiveness of the Frailty Index and Frailty Phenotype in older hospitalized patients
Aging 2012
Open access · CC-BY
New nanoformulation of rapamycin Rapatar extends lifespan in homozygous p53−/− mice by delaying carcinogenesis
Ageing and Cancer Research & Treatment 2026
Open access · CC-BY
cGAS-STING pathway drives cellular senescence and inflammaging
Human Mutation 2010
Open access · OA
Molybdenum cofactor deficiency: Mutations in GPHN, MOCS1, and MOCS2
Respiratory Research 2018
Open access · OA
Idiopathic pulmonary fibrosis: pathogenesis and management
Critical Care 2018
Open access · CC-BY